Healthcare companies have revved the deals engine back into high gear. Takeda Pharmaceutical’s possible acquisition of Shire, with its market… Continue Reading
Articles
Even in Pharma, M&A Shouldn’t Be This Easy, Really: Gadfly
M&A shouldn’t be this easy. London-listed drugmaker Shire Plc has nudged Japan’s Takeda Pharmaceutical Co. to up its takeover proposal… Continue Reading
Pharma giant Astellas to invest $1.8bn in M&A diversification bid
Japan’s second-largest drugmaker, Astellas Pharma, is set to use its strong cash position to invest 200 billion yen ($1.86 billion)… Continue Reading
Takeda Pharmaceutical Acquires London-Listed Shire for $62 bn
Takeda Pharmaceutical agreed to buy London-listed Shire for £45.3 billion ($61.50 billion) on Tuesday after the Japanese company raised the… Continue Reading
AI Researcher Daphne Koller Heading New Machine Learning Drug Discovery Venture
In a recent medium.com blog post, Daphne Koller — an artificial intelligence researcher at the Department of Computer Science at… Continue Reading
M&A, asset sales and spin-offs in pharmaceutical and medical device industries
Mergers and acquisitions (M&A), asset sales, spin-offs and similar activities in the pharmaceutical, medical device and other health-related industries were… Continue Reading
Garmin to work with University of Kansas Medical Center and more digital health deals
Garmin and the University of Kansas Medical Center are taking a closer look at the role wearables can play in… Continue Reading
Patient Empowerment and the Future of Pharma Advertising
In the wake of the recent Facebook scandal and the continued emergence of our existence within a data-driven world, the… Continue Reading
How Big Pharma is Using AI for Drug Discovery, Clinical Trials, and More
Like almost any field in the healthcare industry pharma wants to get in on the latest technology trends. Recently big… Continue Reading
Pharma playing catch-up as GDPR deadline nears
One month remains until Europe’s General Data Protection Regulation (GDPR) comes into force, affecting the way pharma uses people’s data,… Continue Reading